217 OPERAM: intervention protocol 33. Spee J, van Marum J, Egberts T, Drenth-van Maanen C, Jansen PAF. Gestructureerde medicatieanamnese bij opname. Ned Tijdschr Geneeskd. 2010;154:1–8. 34. Cullinan S, O’Mahony D, Byrne S. Application of the structured history taking of medication use tool to optimise prescribing for older patients and reduce adverse events. Int J Clin Pharm. 2016;38(2):374–379. 35. Corsonello A, Onder G, Bustacchini S, Provinciali M, Garasta S, Gareri P, et al. Estimating renal function to reduce the risk of adverse drug reactions. Drug Saf. 2012;35(Supp 1):47–54. 36. van den Brand JAJG, van Boekel GAJ, Willems HL, Kiemeney LALM, den Heijer M, Wetzels JFM. Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population. Nephrol Dial Transplant. 2011;26(10):3176–3181. 37. Pisters R, Lane DA, Nieuwlaat R, De Vos CB, Crijns HJGM, Lip GYH. A novel userfriendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey. Chest. 2010;138(5):1093–1100. 38. Drenth-van Maanen AC, van Marum RJ, Knol W, van der Linden CMJ, Jansen PAF. Prescribing optimization method for improving prescribing in elderly patients receiving Polypharmacy. Drugs Aging. 2009;26(8):687–701. 39. Elwyn G, Laitner S, Coulter A, Walker E, Watson P, Thomson R. Implementing shared decision making in the NHS and patients should be the first step in giving patients choice. Br Med J. 2010;341:971–975. 40. Woodward M. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33(4):323–328. 41. Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738–747. 42. Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–834. 43. Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361–1367. 44. Morisky D, Ang A, Krousel-Wood M, Ward H. Predictive validity of a medication adherence measure for hypertension control. J Clin Hypertens. 2008;10(5):348–354. 45. Leendertse AJ, Van Den Bemt PMLA, Bart Poolman J, Stoker LJ, Egberts ACG, Postma MJ. Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study. Value Heal. 2011;14(1):34–40. 46. Leendertse AJ, Egberts ACG, Stoker LJ, van den Bemt PML a. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008;168(17):1890–1896. 3
RkJQdWJsaXNoZXIy MTk4NDMw